The FDA granted tentative approval for Mylan's drug candidate pemetrexed, a generic version of Eli Lilly and Co.'s Alimta, used to treat lung cancer, but it cannot be sold until the expiration of US patents for Alimta.
Tentative approval granted to Mylan generic for lung cancer drug
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.